Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-005351
Filing Date
2025-02-24
Accepted
2025-02-24 19:28:31
Documents
1
Period of Report
2025-02-20

Document Format Files

Seq Description Document Type Size
1 form4-02252025_120228.html 4  
1 form4-02252025_120228.xml 4 3480
  Complete submission text file 0001415889-25-005351.txt   4923
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
Miller Aine (Reporting) CIK: 0002012524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 25658777